Welcome, Guest |
|
TOPIC: Prof Ed Gane's remarks: implications for Twinvir
Prof Ed Gane's remarks: implications for Twinvir 6 years 3 months ago #9908
|
Male Geno 1a F3-4 Tx Naive Contracted early 1970s Diagnosed 2012 Started 12 wks TWINVIR (Sof/Led) on 15 Nov 2015 Pre-treatment VL 1.8 million UND at 8 Dec 2015; UND at 12 Jan 2016 Ended 12 wks TWINVIR on 6 Feb 2016 9 Feb 2016 EOT VL test <15 PCR Negative UND at 3 May 2016 SVR12 |
Prof Ed Gane's remarks: implications for Twinvir 6 years 3 months ago #9921
|
Lives in Bendigo, Victoria No prior treatment Genotype 1b Fibroscan 0 (only showed a bit of a fatty liver) Diagnosed in February 2015 Currently on my last week of treatment taking led/sof Last LFT normal Insomnia the only side effect Undetected at 4 weeks SVR4 - undetected - all bloods good and GP very happy SVR12 bloods to be done at end of April 2016 SVR12 - undetected!!! |
Prof Ed Gane's remarks: implications for Twinvir 6 years 3 months ago #9930
|
Asif Mostafa M. Pharm (DU), MBA (IBA) Senior Brand Manager Incepta Pharmaceuticals Ltd. 40 Shahid Tajuddin Sharani,Tejgaon 1/A, Dhaka-1208 Phone:8891688-703 (Ex. 155) Fax: +880-2-8891190 Mobile: +88-01713-338492 Available at Viber and whatsapp E-mail: This email address is being protected from spambots. You need JavaScript enabled to view it. |
Prof Ed Gane's remarks: implications for Twinvir 6 years 3 months ago #9931
|
M, 57, Live in Wellington,NZ. Genotype 1a diagnosed in 2013. Treating for the first time since October 31 with Buyers Club Sof/Led. Thanks so much guys. Minimal side effects apart from sore throat at the start.. Viral load 5.4m when treatment started, Undetected at 4 weeks, 8 weeks, End of Treatment and 12-weeks post EOT. Yay! |
Prof Ed Gane's remarks: implications for Twinvir 6 years 3 months ago #9932
|
YMMV |
Prof Ed Gane's remarks: implications for Twinvir 6 years 3 months ago #9944
|
Diagnosed Jan 2015: GT3, A0+F0/F1. Fatigue + Brain-Fog. Started Sof+Dac from fixHepC 10-Nov-2015. NO sides. Pre-Tx: AST 82, ALT 133, Viral Load 1 900 000. Week4: AST 47, ALT 58. VL < 15 (unquantifiable). Week12 (EOT): AST 30, ALT 26, VL UND Week16 (EOT+4): AST 32, ALT 28, GGT 24, VL UND Week28 (EOT+16): AST 26, ALT 22, GGT 24, VL UND Ever grateful to Dr James. Relapsed somewhere after all that... Bummer! Jan 2018: VL 63 000 (still GT3). |
Prof Ed Gane's remarks: implications for Twinvir 6 years 3 months ago #9950
|
M, 57, Live in Wellington,NZ. Genotype 1a diagnosed in 2013. Treating for the first time since October 31 with Buyers Club Sof/Led. Thanks so much guys. Minimal side effects apart from sore throat at the start.. Viral load 5.4m when treatment started, Undetected at 4 weeks, 8 weeks, End of Treatment and 12-weeks post EOT. Yay! |
Prof Ed Gane's remarks: implications for Twinvir 6 years 3 months ago #9952
|
Male Geno 1a F3-4 Tx Naive Contracted early 1970s Diagnosed 2012 Started 12 wks TWINVIR (Sof/Led) on 15 Nov 2015 Pre-treatment VL 1.8 million UND at 8 Dec 2015; UND at 12 Jan 2016 Ended 12 wks TWINVIR on 6 Feb 2016 9 Feb 2016 EOT VL test <15 PCR Negative UND at 3 May 2016 SVR12 |
Prof Ed Gane's remarks: implications for Twinvir 6 years 3 months ago #9953
|
HCV 35 yrs G1a F3 Tx naive started Lesovir-C 15/12/2015 pre tx: VL 5,250,000 ALT 374 AST 208 FIBROSCORE 10.4 4 weeks tx ALT 29/ AST 33. VL < 12 UI/mL 8 weeks tx ALT 29/ AST 34. VL UND 4 weeks after tx UND. SVR4. ALT 24/AST 18 |
Prof Ed Gane's remarks: implications for Twinvir 6 years 3 months ago #9954
|
This email address is being protected from spambots. You need JavaScript enabled to view it. forums.delphiforums.com/generichcvtx G 1a F-1 Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil 11/17/15 4 wk lab ALT 17 AST 16 <15 11/18/15 Started Harvoni 12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND 1/14/16 Fin. Tx 7/07/16 UND SVR 24 |
Prof Ed Gane's remarks: implications for Twinvir 6 years 3 months ago #9955
|
Diagnosed Jan 2015: GT3, A0+F0/F1. Fatigue + Brain-Fog. Started Sof+Dac from fixHepC 10-Nov-2015. NO sides. Pre-Tx: AST 82, ALT 133, Viral Load 1 900 000. Week4: AST 47, ALT 58. VL < 15 (unquantifiable). Week12 (EOT): AST 30, ALT 26, VL UND Week16 (EOT+4): AST 32, ALT 28, GGT 24, VL UND Week28 (EOT+16): AST 26, ALT 22, GGT 24, VL UND Ever grateful to Dr James. Relapsed somewhere after all that... Bummer! Jan 2018: VL 63 000 (still GT3). |
Prof Ed Gane's remarks: implications for Twinvir 6 years 3 months ago #9957
|
Sob/Dac from Oct 29 2015 Geno 1b Fiberscan 9.9 Pre treatment Fiberscan 7.4 week 10 VL 1.3 million pre treatment Week 2.5 VL 96 Week 5.5 VL 17 Week 10 VL UD SVR 3 UD SVR 16 UD Cured: All liver functions in normal ranges. |
Prof Ed Gane's remarks: implications for Twinvir 6 years 3 months ago #9962
|
G3a since '78 - Dx '12 - F4 (2xHCC) 24wk Tx - PEG/Riba/Dac 2013 relapsed 24wk Tx - Generic Sof/Dac/Riba 2015/16 relapsed 16wk Tx - 12/01/17 -> 03/05/17 NS3/NS5a + Generic Sof SVR7 - 22/06/17 UND SRV12 - 27/07/17 UND SVR24 - 26/10/17 UND ![]() ![]() ![]() |
Prof Ed Gane's remarks: implications for Twinvir 6 years 3 months ago #9964
|
This email address is being protected from spambots. You need JavaScript enabled to view it. forums.delphiforums.com/generichcvtx G 1a F-1 Started tx 10/23/15 (Meso sof & led) ALT 48 AST 28 v/l 1.6 mil 11/17/15 4 wk lab ALT 17 AST 16 <15 11/18/15 Started Harvoni 12/16/15 8 wk lab ALT: 15 AST: 13 V/l UND 1/14/16 Fin. Tx 7/07/16 UND SVR 24 |
Prof Ed Gane's remarks: implications for Twinvir 6 years 3 months ago #9968
|
Genotype 1b 42 years. 2007 48 Weeks Interferon + Ribavirin Relapsed. 2015 6 Weeks same as above + Sempivir Too many sides stopped. 7/11/15 started Sof / Dac + Riba 24 Weeks. Kingswood Pharmacy. VL Before tx 3 million. 1st bloods 8 weeks undetected . |
|